Aldehyde dehydrogenase 2 preserves mitochondrial morphology and attenuates hypoxia/reoxygenation-induced cardiomyocyte injury.
Aldehyde dehydrogenase 2
Dynamin-related protein 1
Mitochondrial dynamics
Mitochondrial fission/fusion
Myocardial hypoxia/reoxygenation injury
Journal
World journal of emergency medicine
ISSN: 1920-8642
Titre abrégé: World J Emerg Med
Pays: China
ID NLM: 101549691
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
6
10
2020
Statut:
ppublish
Résumé
Disturbance of mitochondrial fission and fusion (termed mitochondrial dynamics) is one of the leading causes of ischemia/reperfusion (I/R)-induced myocardial injury. Previous studies showed that mitochondrial aldehyde dehydrogenase 2 (ALDH2) conferred cardioprotective effect against myocardial I/R injury and suppressed I/R-induced excessive mitophagy in cardiomyocytes. However, whether ALDH2 participates in the regulation of mitochondrial dynamics during myocardial I/R injury remains unknown. In the present study, we investigated the effect of ALDH2 on mitochondrial dynamics and the underlying mechanisms using the H9c2 cells exposed to hypoxia/reoxygenation (H/R) as an Cardiomyocyte apoptosis was significantly increased after oxygen-glucose deprivation and reoxygenation (OGD/R), and ALDH2 activation largely decreased the cardiomyocyte apoptosis. Additionally, we found that both ALDH2 activation and overexpression significantly inhibited the increased mitochondrial fission after OGD/R. Furthermore, we found that ALDH2 dominantly suppressed dynamin-related protein 1 (Drp1) phosphorylation (Ser616) and adenosine monophosphate-activated protein kinase (AMPK) phosphorylation (Thr172) but not interfered with the expression levels of mitochondrial shaping proteins. We demonstrate the protective effect of ALDH2 against cardiomyocyte H/R injury with a novel mechanism on mitochondrial fission/fusion.
Sections du résumé
BACKGROUND
BACKGROUND
Disturbance of mitochondrial fission and fusion (termed mitochondrial dynamics) is one of the leading causes of ischemia/reperfusion (I/R)-induced myocardial injury. Previous studies showed that mitochondrial aldehyde dehydrogenase 2 (ALDH2) conferred cardioprotective effect against myocardial I/R injury and suppressed I/R-induced excessive mitophagy in cardiomyocytes. However, whether ALDH2 participates in the regulation of mitochondrial dynamics during myocardial I/R injury remains unknown.
METHODS
METHODS
In the present study, we investigated the effect of ALDH2 on mitochondrial dynamics and the underlying mechanisms using the H9c2 cells exposed to hypoxia/reoxygenation (H/R) as an
RESULTS
RESULTS
Cardiomyocyte apoptosis was significantly increased after oxygen-glucose deprivation and reoxygenation (OGD/R), and ALDH2 activation largely decreased the cardiomyocyte apoptosis. Additionally, we found that both ALDH2 activation and overexpression significantly inhibited the increased mitochondrial fission after OGD/R. Furthermore, we found that ALDH2 dominantly suppressed dynamin-related protein 1 (Drp1) phosphorylation (Ser616) and adenosine monophosphate-activated protein kinase (AMPK) phosphorylation (Thr172) but not interfered with the expression levels of mitochondrial shaping proteins.
CONCLUSIONS
CONCLUSIONS
We demonstrate the protective effect of ALDH2 against cardiomyocyte H/R injury with a novel mechanism on mitochondrial fission/fusion.
Identifiants
pubmed: 33014221
doi: 10.5847/wjem.j.1920-8642.2020.04.007
pii: WJEM-11-246
pmc: PMC7517403
doi:
Types de publication
Journal Article
Langues
eng
Pagination
246-254Informations de copyright
Copyright: © 2020 World Journal of Emergency Medicine.
Déclaration de conflit d'intérêts
Conflicts of interest: The authors declare that there is no conflict of interest.
Références
Circulation. 2010 May 11;121(18):2012-22
pubmed: 20421521
J Am Heart Assoc. 2013 Oct 08;2(5):e000461
pubmed: 24103571
Shock. 2016 Feb;45(2):192-7
pubmed: 26555744
Cardiovasc Res. 2010 Oct 1;88(1):16-29
pubmed: 20631158
FEBS Lett. 1987 May 11;215(2):233-6
pubmed: 3582651
Biochim Biophys Acta. 2016 Dec;1862(12):2199-2210
pubmed: 27412473
Int J Cardiol. 2018 Apr 15;257:150-159
pubmed: 29506687
Front Pharmacol. 2016 Apr 21;7:101
pubmed: 27148058
J Cell Physiol. 2018 Aug;233(8):5589-5597
pubmed: 29528108
Biochim Biophys Acta. 2013 Jan;1833(1):233-41
pubmed: 22450031
Free Radic Biol Med. 2013 Dec;65:371-379
pubmed: 23867156
Physiol Rep. 2017 Jun;5(11):
pubmed: 28576854
J Clin Invest. 2013 Jan;123(1):92-100
pubmed: 23281415
Free Radic Biol Med. 2011 Nov 1;51(9):1736-48
pubmed: 21871561
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5969-74
pubmed: 23530233
Annu Rev Physiol. 2019 Feb 10;81:1-17
pubmed: 30256725
Nat Commun. 2014 Apr 07;5:3596
pubmed: 24710105
J Cell Mol Med. 2017 Nov;21(11):2643-2653
pubmed: 28941171
J Cell Sci. 2017 Sep 15;130(18):2953-2960
pubmed: 28842472
Trends Endocrinol Metab. 2015 Aug;26(8):422-9
pubmed: 26160707
Nat Cell Biol. 2011 Feb;13(2):132-41
pubmed: 21258367
J Physiol. 2006 Jul 1;574(Pt 1):95-112
pubmed: 16690706
Front Pharmacol. 2019 Feb 12;10:61
pubmed: 30809145
Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1107-14
pubmed: 17496214
Science. 2011 Jan 28;331(6016):456-61
pubmed: 21205641
Science. 2008 Sep 12;321(5895):1493-5
pubmed: 18787169
Science. 2016 Jan 15;351(6270):275-281
pubmed: 26816379
Essays Biochem. 2018 Jul 20;62(3):341-360
pubmed: 30030364
J Clin Invest. 2009 May;119(5):1275-85
pubmed: 19349686
Theranostics. 2018 Jan 1;8(4):1027-1041
pubmed: 29463997
Nat Rev Dis Primers. 2019 Jun 6;5(1):39
pubmed: 31171787
Cell Res. 2013 Jul;23(7):915-30
pubmed: 23689279
FASEB J. 2014 Jan;28(1):316-26
pubmed: 24076965
Crit Care Med. 2016 Jul;44(7):e544-52
pubmed: 26757166
Cell Death Differ. 2017 Jun;24(6):1111-1120
pubmed: 28498369
J Cardiovasc Pharmacol. 2014 Jun;63(6):477-87
pubmed: 24477044
Cell Death Dis. 2015 Dec 03;6:e2007
pubmed: 26633713
N Engl J Med. 2007 Sep 13;357(11):1121-35
pubmed: 17855673
Biochem J. 2006 Apr 1;395(1):57-64
pubmed: 16321138
N Engl J Med. 2013 Dec 5;369(23):2236-51
pubmed: 24304053
Biochim Biophys Acta. 1996 May 31;1301(1-2):67-75
pubmed: 8652652
Eur Heart J. 2011 Apr;32(8):1025-38
pubmed: 20705694